Effects of COVID-19 on lung function and gas exchange

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022082

Enrollment

124

Registered

2020-06-15

Start date

2021-02-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J84 J18 U07.1

Interventions

Group 1: Examination of lung volumes via bodyplethysmography, physical endurance via spiroergometry/6-minute walk test and diffusion capacity (TLCO) after 8,12,16 and 26 weeks after recovery from COVI

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: PCR detection of SARS-CoV-19

Exclusion criteria

Exclusion criteria: acute infection, history of coronary heart disease (CHD); patients with lung fibrosis or impaired pulmonary diffusion capacity

Design outcomes

Primary

Measure	Time frame
Comparison of TLCO after recovery from COVID-19 after 12 weeks.	—

Secondary

Measure	Time frame
- longitudinal changes of pulmonary function and physical endurance after recovery of COVID-19 - predictive role of FEV1/VC to estimate TLCO - markers to predict patients with mild or severe progress	—

Countries

Germany

Contacts

Public ContactSarah Faust

Klinik für Lungenheilkunde und Beatmungsmedizin

sarah.faust@rheinmaasklinikum.de02405 62-1110

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026